Flash e-reader

 Go to e-reader chapter








PDF FormatRequires Adobe Acrobat Reader

Table 15.4a

Steroid Avoidance Rate at Discharge, 2000 to 2009

Recipients of Deceased Donor Kidneys

Discharge Regimen Year of Transplant
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009
Total Patients 6,403 6,712 6,973 7,129 7,602 8,074 8,687 8,760 8,817 8,578
Steroids Avoided 256 341 513 979 1,521 2,107 2,726 2,811 2,846 2,714
Rate 4.0% 5.1% 7.4% 13.7% 20.0% 26.1% 31.4% 32.1% 32.3% 31.6%
CyA Patients 214 104 91 105 114 51 39 35 13 16
Steroids Avoided 4 2 2 11 12 10 11 8 1 0
Rate 1.9% 1.9% 2.2% 10.5% 10.5% 19.6% 28.2% 22.9% 7.7% 0.0%
Tac Patients 234 341 394 221 277 357 290 272 268 398
Steroids Avoided 34 78 154 65 90 132 156 97 115 156
Rate 14.5% 22.9% 39.1% 29.4% 32.5% 37.0% 53.8% 35.7% 42.9% 39.2%
CyA+MMF Patients 2,522 1,970 1,773 1,517 1,281 903 785 635 425 357
Steroids Avoided 45 44 43 97 117 78 169 157 59 42
Rate 1.8% 2.2% 2.4% 6.4% 9.1% 8.6% 21.5% 24.7% 13.9% 11.8%
Tac+MMF Patients 1,994 2,624 3,335 3,744 4,609 5,662 6,469 7,089 7,416 7,233
Steroids Avoided 53 75 125 400 909 1,559 2,094 2,328 2,471 2,318
Rate 2.7% 2.9% 3.7% 10.7% 19.7% 27.5% 32.4% 32.8% 33.3% 32.0%
CyA+Aza Patients 233 123 56 32 14 9 7 10 7 2
Steroids Avoided 1 1 1 2 0 1 0 1 1 1
Rate 0.4% 0.8% 1.8% 6.3% 0.0% 11.1% 0.0% 10.0% 14.3% 50.0%
Tac+Aza Patients 54 84 60 48 26 24 27 17 24 20
Steroids Avoided 1 1 1 1 1 11 9 7 4 3
Rate 1.9% 1.2% 1.7% 2.1% 3.8% 45.8% 33.3% 41.2% 16.7% 15.0%
CyA+Siro Patients 303 294 186 221 211 164 123 124 138 75
Steroids Avoided 2 11 9 55 93 72 41 60 53 34
Rate 0.7% 3.7% 4.8% 24.9% 44.1% 43.9% 33.3% 48.4% 38.4% 45.3%
Tac+Siro Patients 302 452 339 440 331 214 264 114 63 18
Steroids Avoided 30 55 73 117 111 76 66 45 17 7
Rate 9.9% 12.2% 21.5% 26.6% 33.5% 35.5% 25.0% 39.5% 27.0% 38.9%
Siro+MMF Patients 85 257 272 211 207 171 156 79 67 65
Steroids Avoided 5 15 19 35 51 38 60 16 18 29
Rate 5.9% 5.8% 7.0% 16.6% 24.6% 22.2% 38.5% 20.3% 26.9% 44.6%
Other Regimen Patients 462 463 467 590 532 519 527 385 396 394
Steroids Avoided 81 59 86 196 137 130 120 92 107 124
Rate 17.5% 12.7% 18.4% 33.2% 25.8% 25.0% 22.8% 23.9% 27.0% 31.5%


Source: OPTN/SRTR Data as of October 1, 2010.

Includes patients receiving first transplants of any organ with a functioning graft at discharge and any immunosuppressive

drug use recorded at discharge.

CyA: Cyclosporine; Tac: Tacrolimus; MMF: Include MMF(Mycophenolate Mofetil) and MPA(Mycophenolate Sodium); Aza: Azathioprine;

Siro: Sirolimus.